neoadjuvant chemotherapyHER2-low breast cancerbreast cancer
…nically distinct from HER2-0 disease, especially in response to neoadjuvant chemotherapy.Methods A retrospective analysis was performed on 1274 early br…
22articles mentioning treatments
30treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: neoadjuvant chemotherapy ×
neoadjuvant chemotherapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning neoadjuvant chemotherapy
22 articles · page 1 of 2neoadjuvant chemotherapyTNBCandrogen receptor antagonistsClinicalTrials.govtriple-negative breast cancersEMBASEMEDLINE
…mistry [IHC] ≥ 10%) on pathologic complete response (pCR) after neoadjuvant chemotherapy and synthesized immune-contexture data.Methods We performed a P…
95.9%
neoadjuvant chemotherapybreast canceranthracyclinesnational cancer centre
…most prevalent and debilitating symptoms among women undergoing neoadjuvant chemotherapy for breast cancer. This study analysed fatigue trajectories and…
80.7%
chemoradiotherapyneoadjuvant chemotherapymultimodality therapyimmunotherapyadjuvant chemotherapybrachytherapyPeCa
…ase II study by Ottenhof et al evaluated 33 patients undergoing chemoradiotherapy as primary treatment for locoregionally advanced PeCa. They rep…
local ablative therapySABRsystemic therapylocal consolidative therapy
…, ‘non-small cell lung cancer’, ‘local consolidative therapy’, ‘local ablative therapy’, ‘stereotactic radiotherapy’, ‘SBRT’ and ‘SABR’. Searches were…
neoadjuvant chemotherapyNational Natural Science Foundation of ChinaFudan UniversityZhongshan HospitalChinese Academy of SciencesCRLMThe Strategic Priority Research Program
…harbored enhanced amino acid metabolic activity. Interestingly, neoadjuvant chemotherapy could block this status and restore the antitumor immune balanc…
neoadjuvant chemotherapyNACSun Yat-sen University Cancer CenterBeijing Cancer HospitalSYSUCC
…ectal liver metastasis (CRLM) show heterogeneous outcomes after neoadjuvant chemotherapy (NAC) and resection. Overall survival (OS), the gold-standard e…
radical radiotherapyradical cystectomyNeoadjuvant chemotherapyOC-MIBCNACorgan-confined muscle-invasive bladder cancerNational Cancer Registry
…between 1 January 2015 and 31 December 2021 who received either radical radiotherapy or radical cystectomy after NAC. The data will be linked to Hos…
neoadjuvant chemotherapypembrolizumabpembrolizumab-chemotherapydoxorubicincarboplatinpaclitaxelcyclophosphamideTriple-negative breast cancer (TNBC)TNBC
…s. Adding immune checkpoint inhibitors such as pembrolizumab to neoadjuvant chemotherapy has improved pathological response and survival in pivotal tria…
neoadjuvant chemotherapyneoadjuvant chemoimmunotherapypembrolizumabTriple-negative breast cancerCorticosteroidsTNBCKEYNOTE-522 trial
…tes and survival outcomes with the addition of pembrolizumab to neoadjuvant chemotherapy. However, long-term immune-related adverse events (irAEs) remai…
NACTneoadjuvant chemotherapybreast cancerBCHIITexercise interventions
….6 ± 7.8 years) with newly diagnosed stage II–III BC undergoing NACT were randomly assigned to HIIT group (n = 17) and control group…
neoadjuvant chemotherapyhyperthermic intraperitoneal chemotherapylaparoscopic cytoreductive surgerymitomycin Cleft-sided colon canceranalgesiainfection prevention measureslocal wound care
…ft-sided colon cancer with peritoneal metastasis, who underwent neoadjuvant chemotherapy, followed by laparoscopic cytoreductive surgery and hyperthermi…